BioSante, Solvay deal

BTPH granted Solvay subsidiary Solvay Pharmaceuticals B.V. a sub-license in the U.S. and Canada to its estrogen/progestogen combination transdermal hormone replacement gel. BTPH will receive a $2.5 mi...